You are here : English version
Welcome to the Research Center for Respiratory Diseases INSERM UMR 1100
Actualités
TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells.Paget C, Deng S, Soulard D, Priestman DA, Speca S, von Gerichten J, Speak AO, Saroha A, Pewzner-Jung Y, Futerman AH, Mallevaey T, Faveeuw C, Gu X, Platt FM, Sandhoff R, Trottein F.
PLoS Biol. 2019 Mar 1;17(3):e3000169.
2nd International Symposium on Cathepsin C : from 17/04/19 to 18/04/19; Château d'Artigny, 37520 Montbazon
Therapeutic antibodies: A new era in the treatment of respiratory diseases?Sécher T, Guilleminault L, Reckamp K, Amanam I, Plantier L, Heuzé-Vourc'h N.
Pharmacol Ther . 2018 Sep;189:149-172.2016 Nov 10:1-14.
Research Center for Respiratory Diseases
Director : Mustapha SI TAHAR
3 INSERM teams
Contacts
- Address
Centre d'Etude des Pathologies Respiratoires (CEPR)
INSERM U1100
Faculté de Médecine, Université de Tours
10, boulevard Tonnellé
37032 Tours cedex , France
- Secretary
Tél. : 33 (0)2.47.36.60.49
Fax : 33 (0)2.47.36.60.46
E-mail : secretariat.cepr@univ-tours.fr
